Stockreport

CEL-SCI up 11% premarket on development of COVID-19 treatment [Seeking Alpha]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Healthcare | On the Move CEL-SCI up 11% premarket on development of COVID-19 treatment Mar. 9, 2020 8:40 AM ET CEL-SCI Corporation (CVM) Douglas W. House CEL-SCI (NYSE [Read more]